Cambridge
CAQ

Cambridge (CAQ) news

Recent news

AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts

AstraZeneca has announced the opening of a new global strategic R&D center in Kendall Square, Cambridge, Massachusetts, as part of its broader expansion in the United States . The facility, scheduled for completion in 2026, will serve as a strategic R&D hub and will also house Alexion’s new…

AInvest Wire · Oct 5, 2026

City Therapeutics Inc. seeks to list on Nasdaq under 'CTY'

City Therapeutics Inc., a clinical-stage biopharmaceutical company specializing in RNA interference therapeutics, has not yet filed for an initial public offering or listed on a public exchange such as Nasdaq as of September 24, 2026. The company, headquartered in Cambridge, Massachusetts, is…

AInvest Wire · Sep 24, 2026

Colonial - Value-accretive 50/50 partnership

Colonial has announced a 50/50 joint venture with Stoneshield Capital to develop a pan-European Science & Innovation real estate platform, with an initial investment of €200 million in Deeplabs, a leading Spanish operator in the sector. The partnership aims to capitalize on the growing demand for…

AInvest Wire · Sep 23, 2026

Cambridge continues growth with strong first half 2026 results

AInvest Wire · Aug 11, 2026

Japan, UK to create startup support fund: Nikkei

Japan and the United Kingdom are set to establish a joint startup support fund aimed at fostering innovation and economic collaboration between the two nations, according to reports from Nikkei. This initiative aligns with broader efforts to strengthen bilateral ties, including the recently…

AInvest Wire · Jun 11, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.